{"id":"mictonetten-5-mg-coated-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Dry mouth"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Blurred vision"},{"rate":null,"effect":"Urinary retention"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug blocks M3 muscarinic receptors on the detrusor muscle of the bladder, decreasing involuntary contractions and increasing bladder capacity. This mechanism reduces urinary frequency, urgency, and incontinence episodes characteristic of overactive bladder disorder.","oneSentence":"Mictonetten is a muscarinic M3 receptor antagonist that reduces bladder muscle contractions to treat overactive bladder symptoms.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:21:24.547Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Overactive bladder with symptoms of urinary urgency, frequency, and incontinence"}]},"trialDetails":[{"nctId":"NCT00795925","phase":"PHASE2","title":"Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder","status":"COMPLETED","sponsor":"APOGEPHA Arzneimittel GmbH","startDate":"2004-10","conditions":"Overactive Bladder","enrollment":30},{"nctId":"NCT00603343","phase":"PHASE3","title":"Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence","status":"COMPLETED","sponsor":"APOGEPHA Arzneimittel GmbH","startDate":"2004-06","conditions":"Overactive Bladder, Urinary Incontinence, Children","enrollment":303}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mictonetten"],"phase":"phase_3","status":"active","brandName":"Mictonetten 5 mg, coated tablet","genericName":"Mictonetten 5 mg, coated tablet","companyName":"APOGEPHA Arzneimittel GmbH","companyId":"apogepha-arzneimittel-gmbh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mictonetten is a muscarinic M3 receptor antagonist that reduces bladder muscle contractions to treat overactive bladder symptoms. Used for Overactive bladder with symptoms of urinary urgency, frequency, and incontinence.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}